Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 567

1.

Comparison of the clinical symptoms and the effectiveness of neuraminidase inhibitors for patients with pandemic influenza H1N1 2009 or seasonal H1N1 influenza in the 2007-2008 and 2008-2009 seasons.

Kawai N, Ikematsu H, Tanaka O, Matsuura S, Maeda T, Yamauchi S, Hirotsu N, Nishimura M, Iwaki N, Kashiwagi S.

J Infect Chemother. 2011 Jun;17(3):375-81. doi: 10.1007/s10156-010-0179-9. Epub 2010 Dec 1.

PMID:
21120678
[PubMed - indexed for MEDLINE]
2.

Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons.

Kawai N, Ikematsu H, Hirotsu N, Maeda T, Kawashima T, Tanaka O, Yamauchi S, Kawamura K, Matsuura S, Nishimura M, Iwaki N, Kashiwagi S.

Clin Infect Dis. 2009 Dec 15;49(12):1828-35. doi: 10.1086/648424.

PMID:
19911968
[PubMed - indexed for MEDLINE]
Free Article
3.

Persistence of pandemic influenza H1N1 virus in young patients after oseltamivir therapy in the 2009-2010 season: a comparison with seasonal H1N1 with or without H275Y mutation.

Kawai N, Ikematsu H, Iwaki N, Kondou K, Hirotsu N, Kawashima T, Maeda T, Tanaka O, Doniwa K, Iwakuni O, Egashira K, Yamaji K, Kashiwagi S.

J Infect Chemother. 2012 Apr;18(2):180-6. doi: 10.1007/s10156-011-0314-2. Epub 2011 Dec 23.

PMID:
22193710
[PubMed - indexed for MEDLINE]
4.

Increased symptom severity but unchanged neuraminidase inhibitor effectiveness for A(H1N1)pdm09 in the 2010-2011 season: comparison with the previous season and with seasonal A(H3N2) and B.

Kawai N, Ikematsu H, Kawashima T, Maeda T, Ukai H, Hirotsu N, Iwaki N, Kashiwagi S.

Influenza Other Respir Viruses. 2013 May;7(3):448-55. doi: 10.1111/j.1750-2659.2012.00421.x. Epub 2012 Aug 16.

PMID:
22897904
[PubMed - indexed for MEDLINE]
5.

Clinical effectiveness of neuraminidase inhibitors--oseltamivir, zanamivir, laninamivir, and peramivir--for treatment of influenza A(H3N2) and A(H1N1)pdm09 infection: an observational study in the 2010-2011 influenza season in Japan.

Shobugawa Y, Saito R, Sato I, Kawashima T, Dapat C, Dapat IC, Kondo H, Suzuki Y, Saito K, Suzuki H.

J Infect Chemother. 2012 Dec;18(6):858-64. doi: 10.1007/s10156-012-0428-1. Epub 2012 May 29.

PMID:
22644080
[PubMed - indexed for MEDLINE]
6.

Evaluation of a rapid molecular algorithm for detection of pandemic influenza A (H1N1) 2009 virus and screening for a key oseltamivir resistance (H275Y) substitution in neuraminidase.

van der Vries E, Jonges M, Herfst S, Maaskant J, Van der Linden A, Guldemeester J, Aron GI, Bestebroer TM, Koopmans M, Meijer A, Fouchier RA, Osterhaus AD, Boucher CA, Schutten M.

J Clin Virol. 2010 Jan;47(1):34-7. doi: 10.1016/j.jcv.2009.09.030. Epub 2009 Oct 25.

PMID:
19857993
[PubMed - indexed for MEDLINE]
7.

Evaluation of the antiviral drug susceptibility of influenza viruses in Italy from 2004/05 to 2009/10 epidemics and from the recent 2009 pandemic.

Puzelli S, Facchini M, Di Martino A, Fabiani C, Lackenby A, Zambon M, Donatelli I.

Antiviral Res. 2011 Jun;90(3):205-12. doi: 10.1016/j.antiviral.2011.04.003. Epub 2011 Apr 14.

PMID:
21514326
[PubMed - indexed for MEDLINE]
8.

Oseltamivir-resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009-2010.

Meijer A, Jonges M, Abbink F, Ang W, van Beek J, Beersma M, Bloembergen P, Boucher C, Claas E, Donker G, van Gageldonk-Lafeber R, Isken L, de Jong A, Kroes A, Leenders S, van der Lubben M, Mascini E, Niesters B, Oosterheert JJ, Osterhaus A, Riesmeijer R, Riezebos-Brilman A, Schutten M, Sebens F, Stelma F, Swaan C, Timen A, van 't Veen A, van der Vries E, te Wierik M, Koopmans M.

Antiviral Res. 2011 Oct;92(1):81-9. doi: 10.1016/j.antiviral.2011.07.004. Epub 2011 Jul 13.

PMID:
21767571
[PubMed - indexed for MEDLINE]
9.

Clinical effectiveness of oseltamivir for influenza A(H1N1) virus with H274Y neuraminidase mutation.

Kawai N, Ikematsu H, Iwaki N, Kondou K, Hirotsu N, Kawashima T, Maeda T, Tanaka O, Doniwa K, Kashiwagi S.

J Infect. 2009 Sep;59(3):207-12. doi: 10.1016/j.jinf.2009.07.002. Epub 2009 Jul 7.

PMID:
19619898
[PubMed - indexed for MEDLINE]
10.

A randomized, controlled trial comparing traditional herbal medicine and neuraminidase inhibitors in the treatment of seasonal influenza.

Nabeshima S, Kashiwagi K, Ajisaka K, Masui S, Takeoka H, Ikematsu H, Kashiwagi S.

J Infect Chemother. 2012 Aug;18(4):534-43. doi: 10.1007/s10156-012-0378-7. Epub 2012 Feb 16.

PMID:
22350323
[PubMed - indexed for MEDLINE]
11.

Neuraminidase inhibitor susceptibility profile of pandemic and seasonal influenza viruses during the 2009-2010 and 2010-2011 influenza seasons in Japan.

Dapat C, Kondo H, Dapat IC, Baranovich T, Suzuki Y, Shobugawa Y, Saito K, Saito R, Suzuki H.

Antiviral Res. 2013 Sep;99(3):261-9. doi: 10.1016/j.antiviral.2013.06.003. Epub 2013 Jun 17.

PMID:
23791870
[PubMed - indexed for MEDLINE]
12.

Concurrent comparison of epidemiology, clinical presentation and outcome between adult patients suffering from the pandemic influenza A (H1N1) 2009 virus and the seasonal influenza A virus infection.

To KK, Wong SS, Li IW, Hung IF, Tse H, Woo PC, Chan KH, Yuen KY.

Postgrad Med J. 2010 Sep;86(1019):515-21. doi: 10.1136/pgmj.2009.096206. Epub 2010 Aug 5.

PMID:
20693151
[PubMed - indexed for MEDLINE]
13.

Emergence of oseltamivir resistance: control and management of influenza before, during and after the pandemic.

Dixit R, Khandaker G, Ilgoutz S, Rashid H, Booy R.

Infect Disord Drug Targets. 2013 Feb;13(1):34-45. Review.

PMID:
23675925
[PubMed - indexed for MEDLINE]
14.

Detection of the rapid emergence of the H275Y mutation associated with oseltamivir resistance in severe pandemic influenza virus A/H1N1 09 infections.

Wang B, Dwyer DE, Blyth CC, Soedjono M, Shi H, Kesson A, Ratnamohan M, McPhie K, Cunningham AL, Saksena NK.

Antiviral Res. 2010 Jul;87(1):16-21. doi: 10.1016/j.antiviral.2010.04.002. Epub 2010 Apr 10.

PMID:
20385168
[PubMed - indexed for MEDLINE]
15.

Emerging oseltamivir resistance in seasonal and pandemic influenza A/H1N1.

Renaud C, Kuypers J, Englund JA.

J Clin Virol. 2011 Oct;52(2):70-8. doi: 10.1016/j.jcv.2011.05.019. Epub 2011 Jun 17. Review.

PMID:
21684202
[PubMed - indexed for MEDLINE]
16.

Rapid discrimination of oseltamivir-resistant 275Y and -susceptible 275H substitutions in the neuraminidase gene of pandemic influenza A/H1N1 2009 virus by duplex one-step RT-PCR assay.

Nakauchi M, Ujike M, Obuchi M, Takashita E, Takayama I, Ejima M, Oba K, Konomi N, Odagiri T, Tashiro M, Kageyama T; influenza virus surveillance group of Japan.

J Med Virol. 2011 Jul;83(7):1121-7. doi: 10.1002/jmv.22101. Erratum in: J Med Virol. 2011 Aug;83(8):1491. multiple investigator names added.

PMID:
21567417
[PubMed - indexed for MEDLINE]
17.

Oseltamivir-resistant pandemic influenza a (H1N1) 2009 viruses in Spain.

Ledesma J, Vicente D, Pozo F, Cilla G, Castro SP, Fernández JS, Ruiz MP, Navarro JM, Galán JC, Fernández M, Reina J, Larrauri A, Cuevas MT, Casas I, Breña PP; Spanish Influenza Surveillance System (SISS).

J Clin Virol. 2011 Jul;51(3):205-8. doi: 10.1016/j.jcv.2011.04.008. Epub 2011 May 17.

PMID:
21592854
[PubMed - indexed for MEDLINE]
18.

Supply of neuraminidase inhibitors related to reduced influenza A (H1N1) mortality during the 2009-2010 H1N1 pandemic: an ecological study.

Miller PE, Rambachan A, Hubbard RJ, Li J, Meyer AE, Stephens P, Mounts AW, Rolfes MA, Penn CR.

PLoS One. 2012;7(9):e43491. doi: 10.1371/journal.pone.0043491. Epub 2012 Sep 11.

PMID:
22984431
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Oseltamivir-resistant pandemic (H1N1) 2009 virus, Mexico.

Ramirez-Gonzalez JE, Gonzalez-Duran E, Alcantara-Perez P, Wong-Arambula C, Olivera-Diaz H, Cortez-Ortiz I, Barrera-Badillo G, Nguyen H, Gubareva L, Lopez-Martinez I, Díaz-Quiñonez JA, Lezana-Fernández MA, Gatell-Ramírez HL, Cordova Villalobos JA, Hernández-Avila M, Alpuche-Aranda C.

Emerg Infect Dis. 2011 Feb;17(2):283-6. doi: 10.3201/eid1702.100897.

PMID:
21291607
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Comparison of the efficacies of amantadine treatment of swine-origin influenza virus A H1N1 and seasonal influenza H1N1 and H3N2 in Japan (2008-2009).

Miyachi K, Watanabe A, Iida H, Hattori H, Ukai H, Takano T, Hankins RW.

J Infect Chemother. 2011 Aug;17(4):524-9. doi: 10.1007/s10156-011-0217-2. Epub 2011 Mar 1.

PMID:
21360013
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk